Los Altos, California - We are pleased to announce that MaxVal will be a sponsor for the International Intellectual Property Law Association (IIPLA) Annual Meeting in Silicon Valley on October 9th and 10th, 2017. The IIPLA Annual Meeting is one of the leading events for IP experts, law firms, owners, and investors from all over the world. Every year the IIPLA identifies the focus points of the IP community and becomes a dedicated forum for anyone managing IP-related challenges to learn and share best practices.
“IIPLA shares our continued dedication to helping IP professionals manage ever-changing business and technology challenges by leveraging human intelligence and tech-enabled solutions. We are proud to sponsor this event to further discussions and discovery in IP management,” said D. Bommi Bommannan, Founder and CEO of MaxVal Group.
MaxVal, a fast-growing IP management company, helps companies and law firms across the globe manage their intellectual assets efficiently and effectively. MaxVal recently launched SymphonyTM, a data-driven IP management solution that integrates all aspects of IP management into a single platform that handles invention management, docketing, portfolio management, annuity payments, and more.
This year, the IIPLA will host speakers from some of the world’s largest organizations to share their experiences, viewpoints, and solutions for the emerging challenges in the world of intellectual property.
If you are attending this event and would like to know how you can improve your IP management in an easy and cost-effective way, contact email@example.com to schedule a meeting with the MaxVal team.
About MaxVal Group, Inc.
MaxVal is a Silicon Valley-based tech-enabled managed solutions provider known for its cutting edge products and automated solutions. Since 2004, MaxVal has provided technology-enabled solutions and expert services by partnering with patent counsel and patent operations teams to optimize patent lifecycle management with high levels of customer service. MaxVal’s clients range from start-ups to Fortune 100 companies, top U.S. pharmaceutical and medical device manufacturers, and the leading technology-focused patent law firms worldwide.
Contact: Bala Krishnan, 650-472-2290, firstname.lastname@example.org